UK Biotech Financing Holds Up Despite Woodford and Brexit

Neil Woodford’s Fall From Grace And Brexit Dragged On An Otherwise Buoyant Sector

River_Thames
UK biotech gave a strong showing in 2019, but still isn't as well capitalised as US counterparts

More from Business

More from Scrip